Adam Dubow has sold stock and made no open-market buys since Dec 2019

Adam Dubow is a corporate attorney and General Counsel, Chief Compliance Officer, and Secretary of Day One Biopharmaceuticals, Inc., where he leads the company’s legal function and compliance program and serves as a member of the executive leadership team.( He joined Day One in October 2022 after a 22‑year career at Bristol Myers Squibb, where he most recently served as Chief Compliance and Ethics Officer, establishing a global, best‑in‑class compliance program and previously acting as lead counsel for the company’s global research and development organization and regional legal teams in Europe, the Middle East & Africa, Asia Pacific, and Japan.( As an executive insider, he has reported multiple equity transactions in Day One stock in his capacity as the company’s General Counsel and Secretary, including routine sales to cover tax liabilities associated with restricted stock unit settlements and the cash-out of his equity holdings in connection with Day One’s cash merger with Servier.(

Before joining Bristol Myers Squibb, Dubow was a partner at Sedgwick, Detert, Moran & Arnold, specializing in products liability litigation, and he has since built a reputation as a Fortune 100 C‑suite executive with board‑level expertise in corporate governance, risk, ethics, and compliance.( He currently serves on the Global Board of the Healthcare Businesswomen’s Association, reflecting his longstanding commitment to diversity, equity, and inclusion in the healthcare sector.( Dubow holds an undergraduate degree from Brandeis University and a J.D. from Fordham University School of Law, and he is a member of the New York State Bar.(

Written by Perplexity from public sources.